APM
Aptorum Group Limited
NASDAQ · Healthcare · Biotechnology · GB
$8.26
−14.84%Latest reported
- Last report date
- Oct 3, 2025
- EPS actual
- -$0.06
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +65.3%
- Revenue beats (12Q)
- 4
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 12, 2026